By 
FEMY Closed Up 346.32% On
News Of FDA Clearance For
FemaSeed Infertility Treatment.
Femasys, Inc., (NASDAQ:FEMY) saw huge growth today on news of receiving U.S. FDA clearance for FemaSeed®, the companies infertility treatment that is designed to deliver sperm directly to where conception occurs in a woman’s fallopian tube. The action today made FEMY one of the biggest penny stock gainers of the…
Comments